By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Approximately one in eight Americans has taken a GLP-1 or glucagon-like peptide-1 receptor agonist. These medications were originally developed to help manage type 2 diabetes, but they also support ...

Learn how to prevent muscle loss while taking GLP-1 medications, with expert tips on protein intake, strength training, and body composition monitoring.

(CNN) — More than 15 million Americans are now losing weight with GLP-1 drugs. The medications — drugs like Ozempic, Wegovy and Mounjaro that were originally created to treat type 2 diabetes — have ...

Obesity is a significant chronic disease whose prevalence is worsening despite continued interventions and funding. Obesity is also a precursor to many other health conditions, including diabetes, ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.